# S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

> **NCT00288054** · PHASE1 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 24 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** docetaxel
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00288054
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Study closed early due to poor accrual.
- **Last updated:** 2013-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288054, "S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00288054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*